Breakdown | |||||
TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
153.35M | 158.19M | 90.39M | 80.51M | 66.63M | 20.74M | Gross Profit |
21.54M | 27.89M | 23.34M | 20.08M | 16.25M | 5.71M | EBIT |
-2.84M | -787.00K | 3.33M | 2.34M | 3.44M | 1.97M | EBITDA |
-2.01M | 384.00K | 5.87M | 5.61M | 5.90M | 804.93K | Net Income Common Stockholders |
-14.52M | -12.49M | -1.70M | -111.51K | 1.50M | 27.92K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
37.00K | 1.50M | 1.15M | 5.12M | 2.68M | 1.23M | Total Assets |
70.58M | 73.72M | 56.71M | 57.09M | 39.13M | 8.72M | Total Debt |
51.83M | 49.85M | 27.27M | 22.84M | 12.30M | 2.73M | Net Debt |
51.79M | 48.36M | 26.12M | 17.71M | 9.62M | 1.50M | Total Liabilities |
68.74M | 69.64M | 40.27M | 38.62M | 21.81M | 4.85M | Stockholders Equity |
1.85M | 4.08M | 16.44M | 18.47M | 17.32M | 3.87M |
Cash Flow | Free Cash Flow | ||||
3.66M | 3.02M | -3.20M | 3.38M | 24.13K | 479.20K | Operating Cash Flow |
6.65M | 5.93M | -1.27M | 4.04M | 1.97M | 804.89K | Investing Cash Flow |
-3.98M | -26.43M | -3.33M | -12.67M | -16.08M | 894.94K | Financing Cash Flow |
-3.42M | 20.85M | 625.00K | 11.07M | 15.56M | -424.55K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | C$1.21B | 15.80 | 71.61% | 3.33% | 9.38% | 117.85% | |
72 Outperform | C$1.71B | 43.83 | 6.93% | 5.04% | 8.76% | 14.05% | |
72 Outperform | C$23.84M | 20.68 | 4.53% | ― | 4.09% | ― | |
65 Neutral | C$173.09M | ― | -4.48% | ― | -0.69% | 8.08% | |
53 Neutral | $5.23B | 3.23 | -44.27% | 2.82% | 16.82% | 0.11% | |
46 Neutral | C$3.77M | ― | -239.50% | ― | 3.03% | -410.90% | |
$218.78M | 2.41 | 33.87% | 2.26% | ― | ― |
Premier Health of America Inc. announced a transition in its CFO position, appointing Frédéric St-Cyr as the Interim Chief Financial Officer. This change follows the previous CFO, Guy Daoust, taking on the role of interim CEO. The appointment of St-Cyr, who has a strong background in finance and accounting, is expected to support the company during this transition period. This strategic move is likely to impact the company’s operations by ensuring continuity in financial leadership, which is crucial for maintaining its market position in the healthtech industry.
Premier Health of America Inc. reported its second quarter 2025 financial results, highlighting a significant decline in revenues and adjusted EBITDA compared to the previous year, primarily due to decreased volumes in Quebec and British Columbia. The company is undergoing a reorganization, particularly in Quebec, to adapt to market conditions and regulatory impacts such as Quebec’s Bill 10, which has affected its Per Diem segment. Despite these challenges, Premier Health is focusing on cost reduction, debt management, and exploring growth opportunities in the Travel Nurses and Home Care sectors.
Premier Health of America Inc. announced that all matters proposed at its annual general meeting on April 30, 2025, were approved by shareholders. Key decisions included the re-appointment of Raymond Chabot Grant Thornton LLP as auditor, the election of board members Pierre-Luc Toupin, Hubert Marleau, and Jean-Robert Pronovost, and the continuation of the incentive Stock Option Plan. The meeting saw participation from shareholders holding 54.49% of the total issued and outstanding shares, indicating strong stakeholder engagement and support for the company’s strategic direction.